Tetrahydrofuran → Ethyl (2E)-5-(tert-butoxycarbonylamino)5-methylhex-2-enoate

Triethylphoshonoacetate (1.96 ml, 9.8 mmol) was dissolved in tetrahydrofuran (30 ml). Potassium tert-butoxide (1.10 g, 9.8 mmol) was added. The solution was stirred for 40 min at room temperature. A solution of 3-(tert-butoxycarbonylamino)-3-methylbutanal (1.10 g, 5.5 mmol) in Tetrahydrofuran (6 ml) was added. The solution was stirred at room temperature. for 75 min. It was diluted with ethyl acetate (100 ml) and 1N hydrochloric acid (100 ml). The phases were separated. The aqueous phase was extracted with ethyl acetate (2×50 ml). The combined organic phases were washed with saturated sodium hydrogen carbonate solution (60 ml) and dried over magnesium sulfate. The solvent was removed in vacuo. The crude product was purified by column chromatography on silica (90 g) with ethyl acetate/hepatane (1:4) to give 1.27 g of ethyl (2E)-5-(tert-butoxycarbonylamino)-5-methylhex-2-enoate.

1. stirringThe solution was stirred at room temperature
2. waitfor 75 min
3. customThe phases were separated
4. extractionThe aqueous phase was extracted with ethyl acetate (2×50 ml)
5. washThe combined organic phases were washed with saturated sodium hydrogen carbonate solution (60 ml)
6. dry with materialdried over magnesium sulfate
7. customThe solvent was removed in vacuo
8. customThe crude product was purified by column chromatography on silica (90 g) with ethyl acetate/hepatane (1:4)

ORD record

ord-ff4841742e2d4dbeba93a9d4faba5632

Source dataset

uspto-grants-2003_05

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US06566337B1